|
ZNF187 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.10240000000561E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.83263999999905E-05 |
| Normal-vs-Stage2 |
9.833800E-02 |
| Normal-vs-Stage3 |
2.403600E-02 |
| Normal-vs-Stage4 |
1.840030E-04 |
| Stage1-vs-Stage2 |
3.428800E-01 |
| Stage1-vs-Stage3 |
8.045600E-01 |
| Stage1-vs-Stage4 |
2.439200E-01 |
| Stage2-vs-Stage3 |
6.079800E-01 |
| Stage2-vs-Stage4 |
1.183960E-01 |
| Stage3-vs-Stage4 |
3.312800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.228650E-04 |
| Normal-vs-AfricanAmerican |
7.354700E-04 |
| Normal-vs-Asian |
1.691200E-01 |
| Caucasian-vs-AfricanAmerican |
6.846800E-01 |
| Caucasian-vs-Asian |
6.956200E-01 |
| AfricanAmerican-vs-Asian |
6.031200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.08720000002727E-06 |
| Normal-vs-Female |
1.573760E-01 |
| Male-vs-Female |
4.455200E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.656400E-02 |
| Normal-vs-Extreme_Weight |
1.88643999999849E-05 |
| Normal-vs-Obese |
2.875200E-03 |
| Normal-vs-Extreme_Obese |
1.523130E-03 |
| Normal_Weight-vs-Extreme_Weight |
2.044200E-01 |
| Normal_Weight-vs-Obese |
8.568600E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.938600E-01 |
| Extreme_Weight-vs-Obese |
1.930160E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.377800E-01 |
| Obese-vs-Extreme_Obese |
3.579600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.095600E-03 |
| Normal-vs-Age(41-60Yrs) |
1.328140E-02 |
| Normal-vs-Age(61-80Yrs) |
2.08180000005331E-06 |
| Normal-vs-Age(81-100Yrs) |
1.965630E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.845600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.296000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.346000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.360500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.955900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.156000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.242450E-04 |
| Normal-VS-Type2 PRCC |
1.66208999999862E-05 |
| Normal-VS-KIRP CIMP |
3.061600E-03 |
| Normal-VS-Unclassified PRCC |
3.018500E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.117630E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.663800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.958600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.959600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.914840E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.471800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.49820000003598E-06 |
| Normal-vs-N1 |
3.548000E-01 |
| Normal-vs-N2 |
1.279820E-03 |
| N0-vs-N1 |
3.862200E-02 |
| N0-vs-N2 |
2.993200E-01 |
| N1-vs-N2 |
1.085360E-01 |
|
|
